DOI:
10.1055/s-00000131
Synfacts
LinksClose Window
References
Hargdegger LA. * et al. Novartis Pharma, Basel, Switzerland
Toward a Scalable Synthesis and Process for EMA401, Part I: Late Stage Process Development, Route Scouting, and ICH M7 Assessment.
Org. Process Res. Dev. 2020;
24: 1743-1755
DOI: 10.1021/acs.oprd.0c00215.
Access:
We do not assume any responsibility for the contents of the web pages of other providers.